HIGHLIGHTS
- who: Zhengkang Luo and collaborators from the Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden have published the research: Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes, in the Journal: (JOURNAL)
- what: The authors intended to investigate the effects of IL-35 treatment on macrophage polarization and response of pDCs in an experimental T1D, mouse model: multiple low dose streptozotocin (MLDSTZ). This model provides the authors with the opportunity to study the kinetic responses of immune cells in early development of T1D. The authors report . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.